IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Essex Woodlands Management, Inc.

Q2 2020 Holdings

Filed 2020-08-14 | 8 holdings | $22.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Axogen Inc(AXGN)COM05463X106$22.5M2,429,99999.2%
Revance Therapeutics Inc(RVNCEUR)COM761330109$81.6K3,342,0470.4%
Venus Concept, Inc.COM92332W105$43.3K12,417,8560.2%
Eyepoint Pharmaceuticals IncCOM30233G100$31.9K41,909,2190.1%
Tela BIO, Inc.(TELA)COM872381108$18.0K1,391,7680.1%
Medicinova Inc(MNOV)COM NEW58468P206$6.0K1,105,9410.0%
Catalyst Biosciences IncCOM NEW14888D208$46278,6220.0%
Endologix Inc(ELGXEUR)COM NEW29266S304$101125,7470.0%